当前位置: X-MOL 学术Prim. Care Diabetes › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Concordance between sudomotor disorder and the clinical diagnosis of diabetic peripheral neuropathy, according to various clinical guidelines
Primary Care Diabetes ( IF 2.9 ) Pub Date : 2021-06-06 , DOI: 10.1016/j.pcd.2021.05.012
Esther Chicharro-Luna 1 , Ana Belen Ortega-Avila 2 , Aranza Requena-Martínez 1 , Gabriel Gijon Nogueron 2
Affiliation  

Aim

To assess the concordance between variations in Neuropad® results and the those in different diagnostic criteria of Diabetic Peripheral Neuropathy, according to various clinical guidelines.

Methods

A descriptive observational study was conducted of 111 patients with a confirmed diagnosis of diabetes mellitus. The criteria for inclusion in the study were that patients should be aged 18 years or more and have at least 10 years’ history of diabetes mellitus.

Results

73 (65.8%) were male and 38 (34.2%) were female. Their mean age was 57.92 ± 13.24 years (95% CI 55.45–60.38). Healthy Neuropad® findings were obtained for 35 right feet (31.5%) and 31 left feet (27.9%).

Conclusion

Neuropad® is an effective instrument for detecting macro and microvascular complications such as early-stage neuropathy, although its use should always be accompanied by a clinical examination of the foot.



中文翻译:

根据各种临床指南,汗液运动障碍与糖尿病周围神经病变的临床诊断之间的一致性

目的

根据各种临床指南,评估 Neuropad® 结果的差异与糖尿病周围神经病变不同诊断标准的差异之间的一致性。

方法

对 111 名确诊为糖尿病的患者进行了描述性观察研究。纳入研究的标准是患者年龄应在 18 岁或以上,并且至少有 10 年的糖尿病病史。

结果

73 人(65.8%)为男性,38 人(34.2%)为女性。他们的平均年龄为 57.92 ± 13.24 岁(95% CI 55.45–60.38)。35 只右脚 (31.5%) 和 31 只左脚 (27.9%) 获得了 Healthy Neuropad® 结果。

结论

Neuropad® 是一种检测大血管和微血管并发症(例如早期神经病变)的有效工具,但它的使用应始终伴随足部的临床检查。

更新日期:2021-06-06
down
wechat
bug